PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Asensus Surgical, Inc. (ASXC)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US04367G1031

CUSIP

04367G103

Sector

Healthcare

IPO Date

Nov 12, 1992

Highlights

Market Cap

$94.92M

EPS (TTM)

-$0.31

Total Revenue (TTM)

$3.33M

Gross Profit (TTM)

-$2.61M

EBITDA (TTM)

-$34.09M

Year Range

$0.17 - $0.35

Target Price

$0.35

Short %

4.23%

Short Ratio

7.11

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
ASXC vs. SPY
Popular comparisons:
ASXC vs. SPY

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Asensus Surgical, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-0.50%0.00%0.50%Tue 20Wed 21Thu 22Fri 23Sat 24Aug 25Mon 26Tue 27Wed 28Thu 29Fri 300
0.72%
ASXC (Asensus Surgical, Inc.)
Benchmark (^GSPC)

Returns By Period


ASXC

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

3.96%

1M

1.97%

6M

9.03%

1Y

22.16%

5Y*

12.60%

10Y*

11.26%

*Annualized

Monthly Returns

The table below presents the monthly returns of ASXC, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-17.28%13.34%-23.33%7.22%-10.18%48.98%1.06%9.38%
2023128.57%-13.75%-4.35%-3.03%-18.75%-1.92%-27.45%-18.92%-10.00%-14.81%13.04%23.08%-8.57%
2022-19.82%-13.48%-18.18%-28.57%-13.33%2.56%10.00%22.73%-16.67%-6.67%-2.38%-14.63%-68.47%
2021369.84%25.68%-12.63%-35.38%11.43%35.47%-26.18%-5.98%-15.91%-8.65%-20.71%-17.16%76.19%
2020-7.48%-13.24%-70.34%17.14%2.44%28.57%-9.26%-18.37%-12.50%2.86%30.56%34.04%-57.14%
201920.35%-8.46%-4.42%-15.97%-33.00%1.49%0.74%-32.85%-32.61%-62.90%-13.04%-43.46%-95.00%
2018-6.74%5.56%-10.53%1.18%106.40%22.82%22.71%8.41%-0.00%-43.62%-4.89%-27.33%17.10%
201713.08%-10.88%-7.63%-46.28%-27.69%51.06%-1.41%22.86%66.28%106.99%-21.96%-16.45%48.46%
201611.29%16.30%32.40%-64.71%22.00%-33.33%10.66%1.48%23.36%-11.24%1.33%-14.47%-47.58%
20152.06%-3.70%2.45%28.33%19.95%-33.48%9.00%-19.27%-14.39%10.18%5.62%-5.70%-14.78%
2014-0.00%44.24%-21.43%-53.90%-2.55%20.00%-21.23%-0.76%10.66%-5.96%-48.78%38.57%-64.73%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ASXC is 55, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of ASXC is 5555
Overall Rank
The Sharpe Ratio Rank of ASXC is 5151
Sharpe Ratio Rank
The Sortino Ratio Rank of ASXC is 6060
Sortino Ratio Rank
The Omega Ratio Rank of ASXC is 5757
Omega Ratio Rank
The Calmar Ratio Rank of ASXC is 5353
Calmar Ratio Rank
The Martin Ratio Rank of ASXC is 5353
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Asensus Surgical, Inc. (ASXC) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
No data
ASXC
^GSPC

There is not enough data available to calculate the Sharpe ratio for Asensus Surgical, Inc.. We calculate this metric based on the past 12 months of trading data. Please check back later for updated information.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00Tue 20Wed 21Thu 22Fri 23Sat 24Aug 25Mon 26Tue 27Wed 28Thu 29Fri 30
0.29
2.02
ASXC (Asensus Surgical, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Asensus Surgical, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%Tue 20Wed 21Thu 22Fri 23Sat 24Aug 25Mon 26Tue 27Wed 28Thu 29Fri 30
-100.00%
-0.33%
ASXC (Asensus Surgical, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Asensus Surgical, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Asensus Surgical, Inc. was 100.00%, occurring on Oct 30, 2023. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-100%Nov 7, 19966789Oct 30, 2023
-60.42%Mar 15, 199446May 19, 1994274Jun 20, 1995320
-45.93%Aug 11, 199558Nov 1, 1995129May 7, 1996187
-34.59%Jun 6, 199630Jul 18, 199649Sep 26, 199679
-32%Jan 25, 199375May 11, 199376Aug 27, 1993151

Volatility

Volatility Chart

The current Asensus Surgical, Inc. volatility is 21.28%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%20.00%Tue 20Wed 21Thu 22Fri 23Sat 24Aug 25Mon 26Tue 27Wed 28Thu 29Fri 30
21.28%
5.56%
ASXC (Asensus Surgical, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Asensus Surgical, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Asensus Surgical, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab